Breaking: Moderna Jumps on Coronavirus Vaccine Progress

Breaking: Moderna Jumps on Coronavirus Vaccine Progress

Feb 07, 2020

Biotech Moderna rose sharply Friday after the National Institutes of Health (NIH) said progress with the company’s potential coronavirus vaccine continues.

  • The head of the NIH said this afternoon that tests of the vaccine on mice has been free of “glitches.”
  • The treatment could be ready for phase 1 clinical trials on humans in 2-1/2 months, he added.
  • Shares of Moderna Inc (NASDAQ:MRNA) spiked 11%.
  • Join Libertex!

    Practice for free on a demo account with 50,000 euro

    Register
    or start live trading now